Lab offers COVID-19 return-to-work testing services
Quest Diagnostics today announced new workplace services to aid return-to-work efforts, including access to specimen collection options for COVID-19 testing and on-site temperature checks.
The lab said it currently has capacity to perform 200,000 antibody tests per day and is ramping up lab operations with the goal of performing 150,000 molecular diagnostic tests per day by the end of June.
The Centers for Disease Control and Prevention warns that antibody tests may not show whether individuals are immune and should not be the sole basis for decisions about a person’s return to a workplace.
Related News Articles
Headline
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…
Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…
Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…